BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 15608678)

  • 1. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
    Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of PTPRT phosphatase domains in common human cancers.
    Lee JW; Jeong EG; Lee SH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    APMIS; 2007 Jan; 115(1):47-51. PubMed ID: 17223850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women.
    Maruyama N; Miyoshi Y; Taguchi T; Tamaki Y; Monden M; Noguchi S
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):408-14. PubMed ID: 17202311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of caspase-14 gene in common carcinomas.
    Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
    Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
    Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
    Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
    Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.
    Lee JW; Soung YH; Seo SH; Kim SY; Park CH; Wang YP; Park K; Nam SW; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
    Clin Cancer Res; 2006 Jan; 12(1):57-61. PubMed ID: 16397024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of the PIK3CA gene in ovarian and breast cancer.
    Campbell IG; Russell SE; Choong DY; Montgomery KG; Ciavarella ML; Hooi CS; Cristiano BE; Pearson RB; Phillips WA
    Cancer Res; 2004 Nov; 64(21):7678-81. PubMed ID: 15520168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent mutation of the PIK3CA gene in ovarian and breast cancers.
    Levine DA; Bogomolniy F; Yee CJ; Lash A; Barakat RR; Borgen PI; Boyd J
    Clin Cancer Res; 2005 Apr; 11(8):2875-8. PubMed ID: 15837735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma.
    Buttitta F; Felicioni L; Barassi F; Martella C; Paolizzi D; Fresu G; Salvatore S; Cuccurullo F; Mezzetti A; Campani D; Marchetti A
    J Pathol; 2006 Feb; 208(3):350-5. PubMed ID: 16353168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients.
    Tanaka Y; Kanai F; Tada M; Asaoka Y; Guleng B; Jazag A; Ohta M; Ikenoue T; Tateishi K; Obi S; Kawabe T; Yokosuka O; Omata M
    Oncogene; 2006 May; 25(20):2950-2. PubMed ID: 16331247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast.
    Li H; Zhu R; Wang L; Zhu T; Li Q; Chen Q; Wang H; Zhu H
    Exp Mol Pathol; 2010 Feb; 88(1):150-5. PubMed ID: 19818761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.
    Barbareschi M; Buttitta F; Felicioni L; Cotrupi S; Barassi F; Del Grammastro M; Ferro A; Dalla Palma P; Galligioni E; Marchetti A
    Clin Cancer Res; 2007 Oct; 13(20):6064-9. PubMed ID: 17947469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA mutations in breast cancer are associated with poor outcome.
    Li SY; Rong M; Grieu F; Iacopetta B
    Breast Cancer Res Treat; 2006 Mar; 96(1):91-5. PubMed ID: 16317585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma.
    Dunlap J; Le C; Shukla A; Patterson J; Presnell A; Heinrich MC; Corless CL; Troxell ML
    Breast Cancer Res Treat; 2010 Apr; 120(2):409-18. PubMed ID: 19418217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias.
    Yoo NJ; Park SW; Lee SH
    Pathology; 2012 Jan; 44(1):29-32. PubMed ID: 22081132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the BRCA2 gene in hepatocellular carcinomas.
    Katagiri T; Nakamura Y; Miki Y
    Cancer Res; 1996 Oct; 56(20):4575-7. PubMed ID: 8840963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare PIK3CA hotspot mutations in carcinomas of the biliary tract.
    Riener MO; Bawohl M; Clavien PA; Jochum W
    Genes Chromosomes Cancer; 2008 May; 47(5):363-7. PubMed ID: 18181165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA mutations in advanced ovarian carcinomas.
    Wang Y; Helland A; Holm R; Kristensen GB; Børresen-Dale AL
    Hum Mutat; 2005 Mar; 25(3):322. PubMed ID: 15712344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population.
    Abubaker J; Bavi P; Al-Harbi S; Ibrahim M; Siraj AK; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    Oncogene; 2008 Jun; 27(25):3539-45. PubMed ID: 18193083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.